Main Article Content
Abstract
Obesity is a multifactorial disease, and the genetic component occupies an important place in its pathogenesis. One of the most studied and closely associated with monogenic obesity is the FTO (fat mass and obesity associated) gene. At the same time, inherited variants of genes related to the control of lipid metabolism (ADRB2, ADRB3), fatty acid oxidation (PPARG) and its transfer across cell membranes into intestinal cells (FABP2), inflammatory processes (IL6, IL8, TNF, CRP, TLR2), as well as variants of lipoprotein (LPA) and leptin (LEPR) genes may be of great importance in the formation of obesity in adults.
Purpose – to study the contribution of polymorphisms of FTO, ADRB2, ADRB3, FABP2, PPARG, IL6, IL8, TNF, CRP, TLR2, LPA and LEPR genes to the risk of obesity development in Kuzbass residents.
Materials and methods. 256 middle-aged and elderly people living in Kuzbass, an industrial region of Siberia, were examined. 14 variants in 13 genes were selected for genotyping: FTO rs9939609, ADRB2 rs1042713, ADRB3 rs4994, FABP2 rs1799883, PPARG rs1801282, IL6 rs2229238, IL18 rs1946518, CXCL8 rs4073 and rs2227306, TNF rs1800629, CRP rs1130864, TLR2 rs3804099, LPA rs10455872 and LEPR rs1137100.
Results. Genes whose variants were statistically significantly associated with the risk of developing obesity were identified (recessive inheritance model: FTO rs9939609 (OR 1. 88 95% CI (1.03-3.42) p = 0.039) and IL18 rs1946518 (OR 0.44 95% CI (0.23-0.88) p = 0.015); dominant inheritance model: IL6R rs2229238, OR 1.81 95% CI (1.10-3.00) p = 0.02).
Conclusion. This study found associations between inherited variants of FTO, IL18, IL6R genes and risk of obesity in adults.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Alfyorova VI, Mustafina SV. Obesity prevalence in adult population of Russian Federation (literature review). Obesity and metabolism. 2022; 19(1): 96-105. Russian (Алфёрова В.И., Мустафина С.В. Распространенность ожирения во взрослой популяции российской федерации (обзор литературы) //Ожирение и метаболизм. 2022. № 19(1). С. 96-105)
Pavlova ZSh, Golodnikov AI. Obesity = inflammation. Pathogenesis. What is the men's threat? Medical Bulletin of the South of Russia. 2020; 11(4): 6-23. Russian (Павлова З.Ш., Голодников И.И. Ожирение = воспаление. Патогенез. Чем это грозит мужчинам? //Медицинский вестник Юга России. 2020. № 11(4). С. 6-23.) DOI: 10.21886/2219-8075-2020-11-4-6-23
Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Canales FJR, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020; 151(1): 11-21. DOI: 10.4103/ijmr.IJMR1768_17
Farooqi IS. Monogenic human obesity syndromes. Handb Clin Neurol. 2021; 181: 301-310. DOI: 10.1016/B978-0-12-820683-6.00022-1
Borodina SV, Gapparova KM, Zainudinov ZM, Grigoryan OН. Genetic predictors of obesity development. Obesity and Metabolism. 2016; 13(2): 7-13. Russian (Бородина С.В., Гаппарова К.М., Зайнудинов З.М., Григорьян О.Н. Генетические предикторы развития ожирения //Ожирение и метаболизм. 2016. № 13(2). С. 7-13)
Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in Health and Disease. Int J Mol Sci. 2019; 20(3): 1-54. DOI: 10.3390/ijms20030649
Cao X, Huo P, Li W, Li P, He L, Meng H. Interactions among moderate/severe periodontitis, ADIPOQ-rs1501299, and LEPR-rs1137100 polymorphisms on the risk of type 2 diabetes in a Chinese population. Arch Oral Biol. 2019; 103: 26-32. DOI: 10.1016/j.archoralbio.2019.05.014
Zhao X, Yang Y, Sun BF, Zhao Y-L, Yang Y-G. FTO and obesity: mechanisms of association. Curr Diab Rep. 2014; 14(5): 1-9. DOI: 10.1007/s11892-014-0486-0
de Luis DA, Aller R, Conde R, Izaola O, Sagrado MG, Sanz JC. The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet. J Investig Med. 2013; 61(1): 22-26. DOI: 10.2310/JIM.0b013e318276161d
Sobalska-Kwapis M, Suchanecka A, Słomka M, Siewierska-Górska A, Kępka E, Strapagiel D. Genetic association of FTO/IRX region with obesity and overweight in the Polish population. PLoS One. 2017; 12(6): 1-17. DOI: 10.1371/journal.pone.0180295
Piwonska AM, Cicha-Mikolajczyk A, Sobczyk-Kopciol A, Piwonski J, Drygas W, Kwasniewska M, et al. Independent association of FTO rs9939609 polymorphism with overweight and obesity in Polish adults. Results from the representative population-based WOBASZ study. J Physiol Pharmacol. 2022; 73(3): 395-402. DOI: 10.26402/jpp.2022.3.07
Zdrojowy-Wełna A, Bednarek-Tupikowska G, Zatońska K, Kolačkov K, Jokiel-Rokita A, Bolanowski M. The association between FTO gene polymorphism rs9939609 and obesity is sex-specific in the population of PURE study in Poland. Adv Clin Exp Med. 2020; 29(1): 25-32. DOI: 10.17219/acem/111811
Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLoS One. 2015; 10(7): 1-17. DOI: 10.1371/journal.pone.0133494
Aghajani R, Saeidi M, Amiriani T, Marjani M, Amiriani AH, Tabib AA, Marjani A. Genetic polymorphisms -137 (G > C) (rs187238) and -607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran. Arch Physiol Biochem. 2022; 128(6): 1596-1602. DOI: 10.1080/13813455.2020.1784954
Fatima SS, Jamil Z, Abidi SH, Nadeem D, Bashir Z, Ansari A. Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study. World J Diabetes. 2017; 8(6): 304-310. DOI: 10.4239/wjd.v8.i6.304